CancerIQ: Funding, Investors & Team (Oct 2026)
CancerIQ’s technology enables hospitals to identify, evaluate and manage entire patient populations based on individual genetic risk factors. By analyzing family history, running predictive risk models and automating NCCN guidelines, CancerIQ empowers community-based providers with the genetic expertise to prevent cancer or catch it early. The platform has been rapidly adopted by some of the top health systems in the country and fully integrates with genetics laboratories, EHRs, and specialty software vendors to streamline workflow, guide clinician decision making, achieve cost savings, and – most importantly – improve patient outcomes. Learn more about how CancerIQ is scaling the use of genetic testing to predict, preempt and prevent disease at canceriq.com.
CancerIQ has raised $14.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Aug 2024.
CancerIQ Company Profile and Key Stats
Latest funding round on record: Aug 2024.
CancerIQ Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
CancerIQ raised $14.0M in a Series B announced in Mar 2022.
2.4 years later, an undisclosed round was announced in Aug 2024 with no disclosed amount.
CancerIQ Founders and Leadership Team
Contact details for the CancerIQ team: 1 of 2 have an email address on file.
Start 14-day free trial →CancerIQ Funding Compared to Other Biotechnology Startups
Funded Startups Like CancerIQ in Biotechnology and Chicago
Companies Similar to CancerIQ
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
CancerIQ Funding FAQs
What does CancerIQ do?
CancerIQ’s technology enables hospitals to identify, evaluate and manage entire patient populations based on individual genetic risk factors. By analyzing family history, running predictive risk models and automating NCCN guidelines, CancerIQ empowers community-based providers with the genetic expertise to prevent cancer or catch it early. The platform has been rapidly adopted by some of the top health systems in the country and fully integrates with genetics laboratories, EHRs, and specialty software vendors to streamline workflow, guide clinician decision making, achieve cost savings, and – most importantly – improve patient outcomes. Learn more about how CancerIQ is scaling the use of genetic testing to predict, preempt and prevent disease at canceriq.com.
How much funding has CancerIQ raised?
CancerIQ has raised $14.0M across 2 rounds on record.
When did CancerIQ last raise funding?
CancerIQ's most recent funding round on record was announced in Aug 2024. The amount was not disclosed.
Who founded CancerIQ?
FundedIQ lists Olufunmilayo Olopade (Founder) at CancerIQ.
Who is the CEO of CancerIQ?
Feyi Olopade is listed as CEO at CancerIQ.
Where is CancerIQ headquartered?
CancerIQ is based in Chicago, Illinois, United States.
How many employees does CancerIQ have?
CancerIQ is in the 11-50 employee band.
About FundedIQ's CancerIQ Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CancerIQ is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.